New OnTrak Multi-Drug Panel

Five new multi-drug panel configurations are available for the existing OnTrak TesTcard product line of rapid in vitro diagnostics.

The new panel enables test administrators to choose from a menu of various screens (3, 4, 5, and 6 drug panels), providing more flexibility while reducing time and costs. TesTcard can be administered in one of two ways: as a single-step dip-and-read test or as a single-step pipette test. Both methods require no reagent mixing, timing, incubation, or special handling. A patented design incorporates unique latex technology that provides results in three to five minutes and can be interpreted for up to six hours. The new panels are the products of Varian, Inc. (Palo Alto, CA, USA).

"Many of our customers will appreciate the flexibility TesTcard offers, providing them with a quality solution that doesn't compromise the quality of their drug-testing program,” remarked Stephen Schultheis, consumable products vice president and general manager, Varian. "TesTcard's various menu options enable testing to be done for relevant drugs in an affordable and efficient manner.”




Related Links:
Varian